Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 73-84 of 10,592
Drug study icon
RecruitingNCT07412756

Brenipatide in adults with Major Depressive Disorder

This study is recruiting in the United States, in Australia, in Canada, .... It is testing brenipatide for depression.

In United States
DepressionDrugA study involving a medication or substance.From 18 Years to 75 Years
Countries
United States, Australia, Canada, ...
Sponsor
Eli Lilly and Company
Condition
Depression
Drug study icon
RecruitingNCT07410507

Brenipatide in adults with Schizophrenia

This study is recruiting in the United States, in Argentina, in Brazil, .... It is testing brenipatide for schizophrenia.

In United States
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States, Argentina, Brazil, ...
Sponsor
Eli Lilly and Company
Condition
Schizophrenia
Drug study icon
RecruitingNCT07420283

Brenipatide in people with Addiction

This study is recruiting in the United States, in Canada, and in the United Kingdom. It is testing brenipatide for Addiction.

In United States
AddictionDrugFrom 18 Years to 75 Years
Countries
United States, Canada, United Kingdom
Sponsor
Eli Lilly and Company
Condition
Addiction
Drug study icon
RecruitingNCT07219953

Brenipatide in people with Addiction

This study is recruiting in the United States, in the United Kingdom, in Belgium, .... It is testing brenipatide for Addiction.

In United States
AddictionDrugFrom 18 Years to 75 Years
Countries
United States, United Kingdom, Belgium, ...
Sponsor
Eli Lilly and Company
Condition
Addiction
Drug study icon
RecruitingNCT07219966

Brenipatide in people with Moderate-to-Severe Addiction

This study is recruiting in the United States, in the United Kingdom, in Belgium, .... It is testing brenipatide for Addiction.

In United States
AddictionDrugFrom 18 Years to 75 Years
Countries
United States, United Kingdom, Belgium, ...
Sponsor
Eli Lilly and Company
Condition
Addiction
Behavioral study icon
RecruitingNCT05574127

Brief Behavioral Activation for depression

This study is recruiting in the United States. It is testing brief Behavioral Activation for depression.

In United States
DepressionBehavioralOver 65 Years
Countries
United States
Sponsor
Memorial Sloan Kettering Cancer Center
Condition
Depression
Drug study icon
RecruitingNCT06569394

Cannabidiol in Young Adult Cannabis Users

This study is recruiting in the United States. It is testing cannabidiol for Addiction.

In United States
AddictionDrugFrom 18 Years to 25 Years
Countries
United States
Sponsor
University of Colorado, Denver
Condition
Addiction
Biological study icon
RecruitingNCT03588975

MACI for OCD

This study is recruiting in the United States. It is testing MACI for OCD.

In United States
OCDBiologicalFrom 10 Years to 17 Years
Countries
United States
Sponsor
Vericel Corporation
Condition
OCD
Drug study icon
RecruitingNCT07323784

NTX-1472 in Social Anxiety Disorder

This study is recruiting in the United States. It is testing NTX-1472 for anxiety.

In United States
AnxietyDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Newleos Therapeutics, Inc.
Condition
Anxiety
Drug study icon
RecruitingNCT06655883

Suvorexant for Addiction

This study is recruiting in the United States. It is testing suvorexant for Addiction.

In United States
AddictionDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Merck Sharp & Dohme LLC
Condition
Addiction
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.